InMed Pharmaceuticals Inc (INM) — Capital Reinvestment Ratio

Latest as of June 2005: 0.23x

InMed Pharmaceuticals Inc (INM) has a Capital Reinvestment Ratio of 0.23x as of June 2005, meaning it reinvests 0% of its operating cash flow ($265.71K) in capital expenditures ($60.44K). Check InMed Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.23x

Capex / Operating Cash Flow

Operating Cash Flow

$265.71K

USD

Capital Expenditures

$60.44K

USD

Data as of

Jun 2005

Most recent filing

Annual Capital Reinvestment Ratio for InMed Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for InMed Pharmaceuticals Inc from None to None. See how much free cash does InMed Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow